(Q31128154)

29 June 2017

Reduction of beta-amyloid plaques in brain of transgenic mouse model of Alzheimer's disease by EFRH-phage immunization (English)

1 reference

29 June 2017

0 references

0 references

2

Ilse Dewachter

1 reference

29 June 2017

3

Fred Van Leuven

1 reference

29 June 2017

Dan Frenkel

1

1 reference

PubMed ID

12559780

29 June 2017

Beka Solomon

series ordinal

4

1 reference

PubMed ID

12559780

29 June 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

29 June 2017

1 reference

29 June 2017

21

1 reference

29 June 2017

11-12

1 reference

29 June 2017

1060-1065

1 reference

Alzheimer's disease: genes, proteins, and therapy

29 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900609-6

7 January 2021

Recent advances in the genetics of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900609-6

7 January 2021

Regulation of tau phosphorylation in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900609-6

7 January 2021

Alzheimer's disease as proteolytic disorders: anabolism and catabolism of beta-amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900609-6

7 January 2021

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900609-6

7 January 2021

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900609-6

7 January 2021

Unusual spectral energy distribution of a galaxy previously reported to be at redshift 6.68.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900609-6

7 January 2021

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900609-6

7 January 2021

Alzheimer's vaccine: a cure as dangerous as the disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900609-6

7 January 2021

Disaggregation of Alzheimer beta-amyloid by site-directed mAb.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900609-6

7 January 2021

Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer beta-amyloid peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900609-6

7 January 2021

N-terminal EFRH sequence of Alzheimer's beta-amyloid peptide represents the epitope of its anti-aggregating antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900609-6

7 January 2021

Aging increased amyloid peptide and caused amyloid plaques in brain of old APP/V717I transgenic mice by a different mechanism than mutant presenilin1

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900609-6

7 January 2021

Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900609-6

7 January 2021

Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900609-6

7 January 2021

Immunization against Alzheimer's beta -amyloid plaques via EFRH phage administration

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900609-6

7 January 2021

Generation of auto-antibodies towards Alzheimer's disease vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900609-6

7 January 2021

10.1016/S0264-410X(02)00609-6

Identifiers

DOI

1 reference

29 June 2017

1 reference

PubMed ID

12559780